Prognostic Biomarkers in Predicting Mortality in Respiratory Patients With Ventilator-Associated Pneumonia

NCT04739748 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 136

Last updated 2021-02-08

No results posted yet for this study

Summary

The aim of this study is to evaluate prognostic efficiency RDW and NLR for mortality prediction in respiratory patients with VAP.

Conditions

  • Ventilator Associated Pneumonia

Interventions

DIAGNOSTIC_TEST

complete blood picture

Measure the red blood cell distribution width (RDW), the neutrophil-lymphocyte ratio (NLR).

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-06
Primary Completion
2019-12-07
Completion
2019-12-07

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04739748 on ClinicalTrials.gov